Creatine has no beneficial effect on skeletal muscle energy metabolism in patients with single mitochondrial DNA deletions: a placebo-controlled, double-blind 31P-MRS crossover study.
about
Treatment for mitochondrial disordersCreatine for treating muscle disordersCreatine for treating muscle disordersTreatment for mitochondrial disordersCreatine for treating muscle disordersCreatine fails to augment the benefits from resistance training in patients with HIV infection: a randomized, double-blind, placebo-controlled study.Can the use of creatine supplementation attenuate muscle loss in cachexia and wasting?Neuromuscular imaging in inherited muscle diseasesCreatine, L-carnitine, and ω3 polyunsaturated fatty acid supplementation from healthy to diseased skeletal muscle.Why are there no proven therapies for genetic mitochondrial diseases?Mitochondrial Respiratory Defect Causes Dysfunctional Lactate Turnover via AMP-activated Protein Kinase Activation in Human-induced Pluripotent Stem Cell-derived Hepatocytes.What can metabolic myopathies teach us about exercise physiology?Diagnosis and treatment of mitochondrial myopathiesReview of clinical trials for mitochondrial disorders: 1997-2012.Liver disease in mitochondrial disorders.Treatment of glycogenosys type V (McArdle disease) with creatine and ketogenic diet with clinical scores and with 31P-MRS on working leg muscleNew treatments for mitochondrial disease-no time to drop our standards.Molecular diagnostics and mitochondrial dysfunction: a future perspective.Development of pharmacological strategies for mitochondrial disorders.Treatment of central nervous system manifestations in mitochondrial disorders.Creatine as a therapeutic strategy for myopathies.Effect of creatine and pioglitazone on Hk-2 cell line cisplatin nephrotoxicity.Monitoring clinical progression with mitochondrial disease biomarkers.
P2860
Q24200432-DA0A8093-3D12-4941-BA66-49E6A4C1DAF3Q24202243-5EFB0FD3-BCD5-42DC-A5E6-C374796AE7E2Q24236598-7E903A68-6783-404D-AF32-A5130BC35837Q24244543-3D396F4A-52DE-4A9C-96DB-F36E3190531FQ24246414-BD921CF8-5BE7-4E59-BDD7-9BBA44667A66Q33412387-BFEA8089-E3A1-43E7-865E-B1843D526B17Q34000393-715DAB5A-A44A-4C4E-AA9A-0A21F38069E4Q34130501-CD825710-5B5D-4D5C-AFBE-F92F24AE4158Q34177044-6A95512A-F6B3-413A-8B45-607D92B60B48Q35162928-428BEC68-4A39-4BA8-9473-B2392E7C610CQ36444101-CA233C8F-B634-4C99-8FB9-BC42B5E64E15Q36444470-4F4FB75B-6981-492C-B54D-D42AE11753EFQ36634939-DAD18B20-BCD1-4C77-9AE4-2C24D30C6F86Q36762846-E832353E-EC87-4343-B2AE-049468764B79Q36903648-8E8B7F05-D96D-48E8-AD0C-69A0FEE2AF96Q36960379-C4B0833B-6982-49B6-9FDC-1AD13E0417BBQ37140299-28098BA2-28A6-419A-940C-EC2A51277ADAQ37206274-4742B914-DCB7-4DFA-A820-C6C3F49E5CDBQ37686237-758B2900-6445-4E38-A0F4-965F8FCE3519Q37760579-AEE08E18-EC1C-4284-AC50-DD5E5B6FD66FQ37852586-8F0527C1-E19D-44AA-9548-FAA1AC66A707Q38983939-F89A4715-88A6-4586-B9AA-14699A2828EFQ47713915-00B5C71F-65E5-4CD2-BDC4-8B718C831CFF
P2860
Creatine has no beneficial effect on skeletal muscle energy metabolism in patients with single mitochondrial DNA deletions: a placebo-controlled, double-blind 31P-MRS crossover study.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Creatine has no beneficial eff ...... blind 31P-MRS crossover study.
@en
Creatine has no beneficial eff ...... blind 31P-MRS crossover study.
@nl
type
label
Creatine has no beneficial eff ...... blind 31P-MRS crossover study.
@en
Creatine has no beneficial eff ...... blind 31P-MRS crossover study.
@nl
prefLabel
Creatine has no beneficial eff ...... blind 31P-MRS crossover study.
@en
Creatine has no beneficial eff ...... blind 31P-MRS crossover study.
@nl
P2093
P2860
P1476
Creatine has no beneficial eff ...... blind 31P-MRS crossover study.
@en
P2093
A Papassotiropoulos
C Kornblum
M Bogdanow
R Schröder
T Klockgether
P2860
P304
P356
10.1111/J.1468-1331.2004.00970.X
P577
2005-04-01T00:00:00Z